Annual EBIT:
-$139.59M-$87.75M(-169.28%)Summary
- As of today, VRNA annual earnings before interest & taxes is -$139.59 million, with the most recent change of -$87.75 million (-169.28%) on December 31, 2024.
- During the last 3 years, VRNA annual EBIT has fallen by -$84.34 million (-152.66%).
- VRNA annual EBIT is now -1163125.00% below its all-time high of -$12.00 thousand, reached on December 31, 2005.
Performance
VRNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$13.46M+$23.82M(+229.99%)Summary
- As of today, VRNA quarterly earnings before interest & taxes is $13.46 million, with the most recent change of +$23.82 million (+229.99%) on June 1, 2025.
- Over the past year, VRNA quarterly EBIT has increased by +$81.96 million (+119.65%).
- VRNA quarterly EBIT is now at all-time high.
Performance
VRNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$56.15M+$81.96M(+59.35%)Summary
- As of today, VRNA TTM earnings before interest & taxes is -$56.15 million, with the most recent change of +$81.96 million (+59.35%) on June 1, 2025.
- Over the past year, VRNA TTM EBIT has increased by +$75.01 million (+57.19%).
- VRNA TTM EBIT is now -4447.07% below its all-time high of -$1.23 million, reached on June 30, 2016.
Performance
VRNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VRNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -169.3% | +119.7% | +57.2% |
| 3Y3 Years | -152.7% | +166.2% | +16.5% |
| 5Y5 Years | -244.8% | +222.3% | +0.5% |
VRNA EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -169.3% | at low | at high | +119.7% | at high | +64.0% |
| 5Y | 5-Year | -244.8% | at low | at high | +119.7% | -25.1% | +64.0% |
| All-Time | All-Time | >-9999.0% | at low | at high | +119.7% | -4447.1% | +64.0% |
VRNA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $13.46M(+230.0%) | -$56.15M(+59.3%) |
| Mar 2025 | - | -$10.36M(+43.0%) | -$138.11M(+10.9%) |
| Dec 2024 | -$139.59M(-169.3%) | -$18.17M(+55.8%) | -$154.94M(+0.7%) |
| Sep 2024 | - | -$41.08M(+40.0%) | -$156.03M(-19.0%) |
| Jun 2024 | - | -$68.50M(-152.0%) | -$131.16M(-80.5%) |
| Mar 2024 | - | -$27.18M(-41.1%) | -$72.66M(-7.0%) |
| Dec 2023 | -$51.84M(+23.7%) | -$19.26M(-18.8%) | -$67.87M(-6.4%) |
| Sep 2023 | - | -$16.22M(-62.2%) | -$63.78M(-1.9%) |
| Jun 2023 | - | -$10.00M(+55.4%) | -$62.56M(+14.2%) |
| Mar 2023 | - | -$22.40M(-47.7%) | -$72.89M(+3.3%) |
| Dec 2022 | -$67.93M(-23.0%) | -$15.16M(-1.1%) | -$75.41M(+15.0%) |
| Sep 2022 | - | -$15.00M(+26.2%) | -$88.75M(-32.0%) |
| Jun 2022 | - | -$20.33M(+18.4%) | -$67.22M(+10.8%) |
| Mar 2022 | - | -$24.92M(+12.6%) | -$75.39M(-2.7%) |
| Dec 2021 | -$55.25M(+15.0%) | -$28.50M(-536.6%) | -$73.40M(-63.5%) |
| Sep 2021 | - | $6.53M(+122.9%) | -$44.90M(+38.4%) |
| Jun 2021 | - | -$28.49M(-24.2%) | -$72.91M(-31.5%) |
| Mar 2021 | - | -$22.94M(-6.8%) | -$55.43M(+1.8%) |
| Dec 2020 | -$64.97M(-60.5%) | - | - |
| Sep 2020 | - | -$21.48M(-95.1%) | -$56.42M(-8.2%) |
| Jun 2020 | - | -$11.01M(+24.0%) | -$52.13M(+7.9%) |
| Mar 2020 | - | -$14.49M(-53.6%) | -$56.60M(-8.4%) |
| Dec 2019 | -$40.49M | -$9.44M(+45.1%) | -$52.21M(-0.1%) |
| Sep 2019 | - | -$17.19M(-11.0%) | -$52.16M(-19.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$15.48M(-53.2%) | -$43.78M(-21.7%) |
| Mar 2019 | - | -$10.11M(-7.7%) | -$35.99M(-5.6%) |
| Dec 2018 | -$30.49M(+10.2%) | -$9.38M(-6.5%) | -$34.07M(+12.3%) |
| Sep 2018 | - | -$8.81M(-14.7%) | -$38.86M(+4.5%) |
| Jun 2018 | - | -$7.69M(+6.0%) | -$40.68M(+2.5%) |
| Mar 2018 | - | -$8.18M(+42.3%) | -$41.70M(-7.9%) |
| Dec 2017 | -$33.96M(-367.6%) | -$14.18M(-33.4%) | -$38.65M(-57.9%) |
| Sep 2017 | - | -$10.63M(-22.0%) | -$24.47M(-48.5%) |
| Jun 2017 | - | -$8.71M(-70.0%) | -$16.47M(-83.2%) |
| Mar 2017 | - | -$5.13M(>-9900.0%) | -$8.99M(-132.5%) |
| Dec 2016 | -$7.26M(+45.2%) | $0.00(+100.0%) | -$3.87M(0.0%) |
| Sep 2016 | - | -$2.63M(-113.2%) | -$3.87M(-213.2%) |
| Jun 2016 | - | -$1.23M | -$1.23M |
| Dec 2015 | -$13.25M(-124.4%) | - | - |
| Dec 2014 | -$5.90M(-27.1%) | - | - |
| Dec 2013 | -$4.64M(-11.2%) | - | - |
| Dec 2012 | -$4.18M(-45.6%) | - | - |
| Dec 2011 | -$2.87M(+1.2%) | - | - |
| Dec 2010 | -$2.90M(-12.3%) | - | - |
| Dec 2009 | -$2.59M(-19.0%) | - | - |
| Dec 2008 | -$2.17M(+16.0%) | - | - |
| Dec 2007 | -$2.59M(-97.0%) | - | - |
| Dec 2006 | -$1.31M(>-9900.0%) | - | - |
| Dec 2005 | -$12.00K | - | - |
FAQ
- What is Verona Pharma plc annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Verona Pharma plc?
- What is Verona Pharma plc annual EBIT year-on-year change?
- What is Verona Pharma plc quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Verona Pharma plc?
- What is Verona Pharma plc quarterly EBIT year-on-year change?
- What is Verona Pharma plc TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Verona Pharma plc?
- What is Verona Pharma plc TTM EBIT year-on-year change?
What is Verona Pharma plc annual earnings before interest & taxes?
The current annual EBIT of VRNA is -$139.59M
What is the all-time high annual EBIT for Verona Pharma plc?
Verona Pharma plc all-time high annual earnings before interest & taxes is -$12.00K
What is Verona Pharma plc annual EBIT year-on-year change?
Over the past year, VRNA annual earnings before interest & taxes has changed by -$87.75M (-169.28%)
What is Verona Pharma plc quarterly earnings before interest & taxes?
The current quarterly EBIT of VRNA is $13.46M
What is the all-time high quarterly EBIT for Verona Pharma plc?
Verona Pharma plc all-time high quarterly earnings before interest & taxes is $13.46M
What is Verona Pharma plc quarterly EBIT year-on-year change?
Over the past year, VRNA quarterly earnings before interest & taxes has changed by +$81.96M (+119.65%)
What is Verona Pharma plc TTM earnings before interest & taxes?
The current TTM EBIT of VRNA is -$56.15M
What is the all-time high TTM EBIT for Verona Pharma plc?
Verona Pharma plc all-time high TTM earnings before interest & taxes is -$1.23M
What is Verona Pharma plc TTM EBIT year-on-year change?
Over the past year, VRNA TTM earnings before interest & taxes has changed by +$75.01M (+57.19%)